| 1999 |
GBF1 was identified as a novel Golgi-associated guanine nucleotide exchange factor (GEF) with a Sec7 domain that exhibits BFA-resistant guanine nucleotide exchange activity with apparent specificity toward ARF5 at physiological Mg2+ concentrations. Overexpression conferred BFA resistance on Golgi morphology and ARF activation/COPI recruitment. GBF1 is primarily cytosolic but a significant pool co-localizes with COPI beta-subunit at a perinuclear structure and by immunogold labeling to Golgi cisternae and smooth vesiculotubular structures. |
Expression cloning, hexahistidine-tagged in vitro GEF activity assay, immunofluorescence, immunogold EM, subcellular fractionation |
The Journal of cell biology |
High |
10402461
|
| 1998 |
Human GBF1 encodes a 206.5 kDa protein containing a centrally positioned Sec7 domain and a proline-rich C-terminal region. Its mRNA is expressed ubiquitously across 17 tissues. The gene maps to chromosomal locus 10q24 and the Sec7 domain-encoding region harbors four introns. |
cDNA cloning, Northern blotting, chromosomal mapping (YAC, radiation hybrid) |
Genomics |
Medium |
9828135
|
| 2003 |
GBF1 physically interacts with the membrane-tethering protein p115 through the proline-rich region of GBF1 and the head region of p115. The interaction was identified by yeast two-hybrid and confirmed by in vitro binding and co-immunoprecipitation. The two proteins co-localize in the Golgi and peripheral VTCs. Expression of the p115-binding (pro-rich) region of GBF1 caused Golgi disruption, demonstrating functional relevance, but the interaction was not required for targeting either protein to membranes. |
Yeast two-hybrid screen, in vitro binding assay, co-immunoprecipitation, immunofluorescence, domain mutagenesis |
EMBO reports |
High |
12634853
|
| 2004 |
GBF1 cycles rapidly on and off Golgi membranes (fast turnover by FRAP), and BFA, which forms an Arf-GDP–GEF inhibitory complex, stabilizes GBF1 on Golgi membranes. Using an in vivo Arf1-GTP reporter assay, GBF1 exchange activity on Arf1 was shown to be inhibited by BFA in mammalian cells, consistent with formation of an Arf1–GBF1–BFA ternary complex with longer membrane residence. |
YFP-GBF1 FRAP, in vivo Arf1-GTP level assay, BFA treatment |
Molecular biology of the cell |
High |
15616190
|
| 2005 |
GBF1 rapidly cycles between membranes and cytosol with t½ ~17 s. GBF1 is stabilized on membranes when complexed with ARF-GDP (shown by inactive E794K GBF1 mutant, ARF1-T31N mutant, or BFA). GBF1 dissociation from ARF and membranes is triggered by its catalytic activity (GDP displacement and GTP binding to ARF), implying that each GBF1 membrane association catalyzes a single ARF activation event. |
GFP-GBF1 FRAP, expression of catalytically inactive GBF1-E794K mutant, ARF1-T31N expression, BFA treatment |
Traffic (Copenhagen, Denmark) |
High |
15813748
|
| 2006 |
GBF1 localizes to both Golgi membranes and peripheral puncta near but separate from ER exit sites, associating dynamically with both. BFA causes accumulation of GBF1 on these membranes before redistribution to ER in a microtubule-dependent manner. Microinjection of anti-GBF1 antibodies specifically caused dissociation of COPI from membranes, demonstrating that GBF1 regulates COPI membrane recruitment in the early secretory pathway. GBF1 recruitment to cargo-containing peripheral puncta coincided with COPI but not COPII recruitment. |
GFP-GBF1 live-cell imaging, FRAP, diffusion coefficient measurement, subcellular fractionation, anti-GBF1 antibody microinjection, immunofluorescence |
Journal of cell science |
High |
16926190
|
| 2006 |
The enterovirus CVB3 3A protein inhibits ARF1 activation by directly binding to GBF1 at its N-terminus, thereby blocking GBF1-mediated COP-I coat complex recruitment to membranes and inhibiting ER-to-Golgi transport. This mechanism is specific to GBF1 (not BIG1/BIG2) and viral mutants defective in this function are less virulent in mice. |
Co-immunoprecipitation, dominant-negative ARF1 expression, BFA resistance assay in MDCK cells, siRNA knockdown, mouse virulence assay, electron microscopy |
Developmental cell |
High |
16890159
|
| 2006 |
Among multiple picornavirus 3A proteins tested, only enterovirus (CVB3 and poliovirus) 3A proteins inhibit COP-I recruitment via GBF1 binding. The N-terminal residues of CVB3 3A are critical for GBF1 binding; chimeric HRV 3A proteins with CVB3 N-termini gain the ability to bind GBF1 and inhibit transport. Other picornavirus 3A proteins (HRV, EMCV, FMDV, HAV) fail to bind GBF1 or inhibit COP-I recruitment. |
Co-immunoprecipitation, COP-I recruitment assay, protein transport assay, chimeric protein analysis |
Journal of virology |
High |
17005635
|
| 2007 |
The 3A protein of CVB3 must form homodimers to bind GBF1 and trap it on membranes. A conserved region in the N-terminus of 3A is required for GBF1 binding but not dimerization. In GBF1, the extreme N-terminus, the dimerization/cyclophilin binding (DCB) domain, and the homology upstream of Sec7 (HUS) domain are all required for the interaction with viral 3A. A GBF1 mutant lacking its extreme N-terminus cannot rescue the effects of 3A overexpression. |
Mutagenesis of 3A and GBF1, co-immunoprecipitation, functional rescue assay |
Journal of virology |
High |
17329336
|
| 2007 |
Rab1b GTPase directly interacts with GBF1 through GBF1's N-terminal domain, identifying GBF1 as a Rab1b effector. Active Rab1b (Rab1bQ67L) increases GBF1 and COPI association with peripheral ER exit site structures, stabilizes Arf1 on Golgi membranes, and Rab1b siRNA reduces GBF1 membrane association. |
Co-immunoprecipitation, GFP-Rab1b live imaging, FRAP, siRNA knockdown, immunofluorescence |
Molecular biology of the cell |
High |
17429068
|
| 2007 |
GBF1 colocalizes with GGA adaptor proteins on Golgi membranes and physically interacts with GGAs. Depletion of GBF1 or expression of its inactive mutant prevents GGA recruitment to Golgi membranes and results in improper lysosomal cargo sorting (mannose 6-phosphate receptor and sortilin trafficking). |
siRNA knockdown, inactive GBF1 mutant expression, co-immunoprecipitation, immunofluorescence, cargo trafficking assay |
Traffic (Copenhagen, Denmark) |
Medium |
17666033
|
| 2007 |
GBF1 regulates COPI recruitment specifically on cis-Golgi compartments (while BIGs regulate adaptors on trans-Golgi). GBF1 knockdown/COPI knockdown does not prevent ER export of VSVGtsO45 but causes its accumulation in peripheral vesiculotubular clusters, and is required for Golgi subcompartmentalization and cargo progression to the cell surface. GBF1 is required for transmembrane but not soluble protein secretion. |
siRNA knockdown, VSVGtsO45 trafficking assay, immunofluorescence |
Molecular biology of the cell |
High |
18003980
|
| 2007 |
siRNA-mediated depletion of GBF1 causes COPI dispersal but, unlike BFA treatment or expression of inactive ARF, does not cause Golgi collapse into ER. Instead, GBF1 depletion causes extensive tubulation of the cis-Golgi with connections to peripheral ERGIC sites. GBF1 depletion dramatically inhibits transmembrane protein trafficking but soluble proteins continue to be secreted, showing cargo-type specificity. |
siRNA knockdown, live-cell imaging, immunofluorescence, cargo trafficking assays (soluble and transmembrane) |
Journal of cell science |
High |
17956946
|
| 2007 |
The DCB domains of GBF1, BIG1, and BIG2 mediate homodimerization of each GEF, and an intramolecular interaction between DCB and HUS domains (mediated by the conserved HUS box) determines the architecture of the N-terminal regulatory region. Both DCB and HUS domains are necessary for GBF1 dimerization in mammalian cells, and the DCB domain is essential for yeast viability. |
Yeast two-hybrid, biochemical pulldown assays, cellular dimerization assay, yeast complementation |
The Journal of biological chemistry |
High |
17640864
|
| 2008 |
GBF1 depletion by siRNA causes cell-cycle arrest in G0/G1, dispersal of Golgi markers (beta-COP, GM130), induction of ER stress proteins (calreticulin, PDI), and upregulation of UPR chaperones. GBF1 depletion specifically induces relocation of the site-2 protease S2P from Golgi to ER and proteolysis of ATF6, mimicking a UPR response. BIG1 or BIG2 depletion did not reproduce these effects. |
siRNA knockdown, cell-cycle analysis, immunofluorescence, quantitative proteomics, Western blotting |
Proceedings of the National Academy of Sciences of the United States of America |
High |
18287014
|
| 2008 |
MHV coronavirus RNA replication requires GBF1-mediated ARF1 activation. Individual siRNA knockdown of GBF1 (but not BIG1 or BIG2) significantly inhibited MHV RNA replication. ARF1 siRNA also inhibited MHV infection. BFA did not block RC formation per se but reduced RC number. MHV was BFA-insensitive in MDCK cells expressing BFA-resistant GBF1. |
siRNA knockdown (individual targets), BFA pharmacological inhibition in MDCK cells with BFA-resistant GBF1, immunofluorescence, quantitative electron microscopy |
PLoS pathogens |
High |
18551169
|
| 2008 |
GDP-bound class II Arfs (Arf4, Arf5) associate with ERGIC membranes independently of GBF1. After BFA treatment, Arf1 and Arf3 dissociate from endomembranes while Arf4 and Arf5 persist on ERGIC. A GDP-arrested Arf4(T31N) localizes to ERGIC even with BFA and Exo1 present. Loss of Arf-GTP (by Exo1) causes GBF1 accumulation on Golgi and ERGIC membranes, suggesting GBF1 accumulation can be triggered by loss of Arf-GTP rather than only by Arf-GDP–BFA–GBF1 complex formation. |
Live-cell imaging of fluorescently tagged Arfs and GBF1, BFA and Exo1 pharmacological treatments, dominant-negative Arf4(T31N) expression |
Molecular biology of the cell |
Medium |
18524849
|
| 2009 |
CVB3 RNA replication critically requires GBF1. siRNA knockdown of GBF1 inhibited viral RNA replication; overexpression of active but not inactive GBF1 rescued replication in BFA-treated cells. The BFA-resistant GBF1-M832L efficiently rescued both wt and 3A-mutant replicons. BFA-resistant GBF1-A795E rescued wt but not 3A-GBF1 binding-deficient replicons. Overexpression of Arf proteins or Rab1B failed to rescue replication in the presence of BFA. |
siRNA knockdown, BFA-resistant GBF1 overexpression rescue, subgenomic replicon assay, viral RNA replication quantification |
Journal of virology |
High |
19740986
|
| 2009 |
GBF1 is required for HCV RNA replication. Individual siRNA knockdown of GBF1 (but not BIG1 or BIG2) and the GBF1-specific inhibitor Golgicide A inhibited HCV replication. Overexpression of BFA-resistant GBF1 rescued HCV replication in BFA-treated cells. BFA did not block membranous web-like structure formation, suggesting GBF1 is involved in replication complex activity rather than formation. |
siRNA knockdown, specific pharmacological inhibitor (Golgicide A), BFA-resistant GBF1 rescue, immunofluorescence, electron microscopy |
Journal of virology |
High |
19906930
|
| 2009 |
In Drosophila, garz (the GBF1 ortholog) functions in the pinocytic GEEC (GPI-AP enriched early endosomal compartment) pathway for clathrin-independent endocytosis. Live confocal and TIRF imaging show a fraction of GBF1-GFP dynamically associates with activated Arf1-positive nascent pinosomes. A GTP-exchange-deficient GBF1 mutant impairs fluid phase uptake. GBF1 activation is required for the GEEC pathway even in the presence of BFA, indicating a role in endocytosis separable from its role in secretion. |
RNAi knockdown in Drosophila cells, live confocal/TIRF imaging, quantitative fluid-phase uptake assay, GTP-exchange-deficient mutant expression |
PloS one |
Medium |
19707569
|
| 2010 |
For poliovirus replication, GBF1's N-terminal region (lacking the catalytic Sec7 domain) is sufficient to rescue replication in BFA-treated cells. In poliovirus-infected cells, p115 (a normal GBF1 modulator) is degraded and neither p115 nor Rab1b knockdown affects virus replication, indicating that GBF1 supports viral replication through functions distinct from its canonical Arf-activating role in COPI vesicle formation. |
BFA-resistant GBF1 domain rescue assay (N-terminal fragment lacking Sec7), siRNA knockdown of p115 and Rab1b, viral replication assay |
Cellular microbiology |
High |
20497182
|
| 2010 |
The phosphatidylinositol 4-kinase PI4KIIIα is required for GBF1 recruitment to Golgi membranes. Inhibitors of PI4P synthesis or depletion of PI4KIIIα prevents GBF1 recruitment to the Golgi. Dominant-active Rab1b increases PI4P levels at the Golgi as detected by GFP-PH sensor, suggesting Rab1b contributes to GBF1 recruitment through activation of PI4KIIIα and subsequent PI4P production. |
PI4P synthesis inhibitors, siRNA knockdown of PI4KIIIα, GFP-PH PI4P biosensor, dominant-active Rab1b expression, immunofluorescence |
Journal of cell science |
Medium |
20530568
|
| 2010 |
GBF1 is phosphorylated by CDK1-cyclin B in mitosis, which results in its dissociation from Golgi membranes. This is accompanied by a reduction in membrane-associated GTP-bound ARF in mitotic cells. Despite reduced GBF1 and ARF-GTP, COPI binding to Golgi appears unaffected but remains GBF1-dependent, suggesting a low level of GBF1 activity persists in mitosis. |
Identification of GBF1 as Golgi phosphoprotein, in vitro kinase assay with CDK1-cyclin B, phosphorylation site mapping, immunofluorescence, membrane fractionation, cell synchronization |
The Biochemical journal |
High |
20175751
|
| 2011 |
C. trachomatis selectively co-opts GBF1 (not BIG1 or BIG2) for vesicle-mediated sphingomyelin (SM) acquisition. The GBF1/Arf1-dependent pathway provides SM essential for inclusion membrane growth and stability but is not required for bacterial replication. A separate CERT-dependent non-vesicular ceramide transport pathway provides SM required for bacterial replication. |
siRNA knockdown of individual GEFs, BFA pharmacological inhibition, fluorescent lipid transport assays, inclusion growth/stability quantification, bacterial replication assay |
PLoS pathogens |
High |
21909260
|
| 2011 |
GBF1 and ATGL (adipose triglyceride lipase) interact directly and in cells. Yeast two-hybrid, co-immunoprecipitation, and direct protein binding assays demonstrate interaction through multiple contact sites. The C-terminal region of ATGL interacts with N-terminal domains of GBF1 including the Sec7 domain (but not full-length GBF1). The ATGL patatin domain interacts with GBF1's HDS1 and HDS2 C-terminal domains. HDS1 and HDS2 expressed alone localize to lipid droplets but not Golgi, unlike full-length GBF1. |
Yeast two-hybrid, co-immunoprecipitation in mammalian cells, direct protein binding, fluorescence microscopy |
PloS one |
Medium |
21789191
|
| 2012 |
In Drosophila, loss of garz (GBF1 ortholog) impairs Golgi complex integrity, disrupts vesicle transport of cargo proteins and directed apical membrane delivery, and perturbs polarized epithelial architecture of tubular organs (salivary glands, trachea, proventriculus, hindgut). These phenotypes are caused by dysfunction of the Arf1-COPI machinery. |
Drosophila loss-of-function mutant analysis (EMS and targeted), immunofluorescence, electron microscopy, cargo trafficking assays in embryos |
Journal of cell science |
High |
22302994
|
| 2012 |
GBF1 bears a novel phosphatidylinositol-phosphate binding module (BP3K) that binds products of PI3Kγ. Upon GPCR stimulation in neutrophils, GBF1 is translocated from the Golgi to the leading edge to activate Arf1, which recruits p22phox and GIT2 to the leading edge. GBF1-mediated Arf1 activation is required for neutrophil chemotaxis and superoxide production, linking PI3Kγ activity with Arf1 activation. |
PI3P/PI4P binding assays, immunofluorescence (GBF1 localization on GPCR stimulation), siRNA knockdown, superoxide production assay, chemotaxis assay |
Molecular biology of the cell |
Medium |
22573891
|
| 2012 |
GBF1 and ARF1 colocalize with PI4KIIIβ at HCV replication complexes. Both ARF1 and GBF1 are required for HCV replication; overexpression of PI4P phosphatase Sac1 inhibits HCV replication. PI4KIIIβ is required for HCV replication and co-localizes with the GBF1/ARF1 machinery, suggesting GBF1/ARF1 generates a PI4P-enriched environment supporting HCV replication. |
Immunofluorescence co-localization, siRNA knockdown, PI4P phosphatase overexpression, HCV replication assay |
PloS one |
Medium |
22359663
|
| 2013 |
GBF1-activated ARFs (specifically ARF4 and ARF5, but not ARF3) facilitate BIG1 and BIG2 recruitment to the TGN, establishing a functional cascade between GEFs. GBF1 is ultrastructurally localized to pre-Golgi, Golgi, and also TGN, and its activity at the TGN is required for subsequent BIG1/2 recruitment that coordinates clathrin adaptor coating events. |
siRNA knockdown, immunofluorescence, ultrastructural localization (immunoelectron microscopy), ARF isoform-specific knockdown |
The Journal of biological chemistry |
High |
23386609
|
| 2013 |
GBF1 possesses a lipid-binding HDS1 domain immediately downstream of the catalytic Sec7 domain. An amphipathic helix within HDS1 is necessary and sufficient for binding to lipid droplets and Golgi membranes in cells and to bilayer liposomes and artificial lipid droplets in vitro. The catalytic Sec7 domain inhibits the potent lipid-droplet-binding capacity of HDS1. Additional sequences upstream of the Sec7-HDS1 tandem are required for Golgi membrane localization. |
In vitro liposome binding, in vitro artificial lipid droplet binding, GFP-tagged domain expression in cells, domain deletion/mutagenesis analysis |
Journal of cell science |
High |
23943872
|
| 2013 |
AMPK is phosphorylated and activated when cells enter mitosis. Activated AMPK phosphorylates GBF1, dissociating GBF1 from Golgi membranes and abolishing its Arf1-GEF activity. AMPK and GBF1 phosphorylation are essential for mitotic Golgi disassembly and subsequent mitosis entry. |
Cell synchronization, phosphorylation assays, kinase assays (AMPK on GBF1), immunofluorescence, Golgi fragmentation quantification, rescue/inhibition experiments |
Journal of cell science |
Medium |
23418352
|
| 2013 |
C. elegans GBF-1 localizes to the cis-Golgi and ER-Golgi elements. GBF-1 is required for secretion and Golgi integrity. Additionally, GBF-1 depletion disperses ER reticular structure (without destroying ER exit sites), reduces RAB-5-positive early endosomes, and causes accumulation of RAB-7-positive late endosomes, revealing a role in receptor-mediated endocytosis and endosomal traffic. |
RNAi knockdown in C. elegans oocytes and intestinal epithelial cells, immunofluorescence/confocal microscopy, endocytosis assays, organelle marker analysis |
PloS one |
Medium |
23840591
|
| 2015 |
The GBF1-Arf1/Arf4-COPI pathway is necessary for dengue virus capsid transport from the ER membrane to lipid droplets (LDs). This process is independent of COPII components and Golgi integrity. A BFA-resistant form of GBF1 restores capsid distribution in infected cells treated with BFA, demonstrating GBF1 catalytic activity is required. |
BFA/drug treatment, BFA-resistant GBF1 rescue, COPII/Golgi disruption, immunofluorescence, siRNA knockdown of Arf1/Arf4 |
Traffic (Copenhagen, Denmark) |
Medium |
26031340
|
| 2015 |
GBF1 oligomerization (mediated by DCB domain residues K91 and E130) is dispensable for Golgi localization, membrane cycling, Arf activation, COPI recruitment, Golgi homeostasis, and cargo secretion, and is not required for poliovirus RNA replication support. However, oligomerization stabilizes GBF1 in cells; the oligomerization-deficient 91/130 mutant is degraded faster than wild-type GBF1. |
Site-directed mutagenesis, FRAP, ARF activation assay, COPI recruitment assay, secretion assay, poliovirus replication assay, protein stability measurement |
American journal of physiology. Cell physiology |
Medium |
26718629
|
| 2016 |
In zebrafish, a missense mutation (L1246R) in the HDS2 domain of gbf1 causes vascular hemorrhage. The mutant Gbf1(L1246R) cannot be recruited to the Golgi apparatus and fails to activate Arf1 for COPI complex recruitment, causing ER stress and endothelial apoptosis via PERK/CHOP. Hemorrhage can be partially prevented by ER stress inhibitor tauroursodeoxycholic acid or knockdown of proapoptotic baxb. |
ENU mutagenesis zebrafish screen, positional cloning, mammalian cell-based Golgi recruitment assay, Arf1 activation assay, COPI recruitment assay, ER stress marker analysis, rescue experiments |
The Journal of biological chemistry |
High |
28003365
|
| 2017 |
GBF1 forms a functional complex with Arf4 and the photoreceptor cargo rhodopsin at the Golgi/TGN during sensory membrane carrier biogenesis. Rhodopsin and Arf4 bind the regulatory N-terminal DCB-HUS domain of GBF1. The complex is sensitive to Golgicide A (GCA), which blocks rhodopsin delivery to cilia. Newly synthesized rhodopsin in the endomembrane system is essential for GBF1-Arf4 complex formation in vivo. GBF1 also interacts with Arf GAP ASAP1 in a GCA-resistant manner. |
Co-immunoprecipitation with recombinant human proteins, frog retina in vivo experiments, GCA inhibitor treatment, domain binding mapping |
Journal of cell science |
Medium |
29025970
|
| 2017 |
GBF1 is involved in the replication of yellow fever virus, Sindbis virus, coxsackievirus B4, and human coronavirus 229E. For HCV and some other viruses, class II Arfs (Arf4/Arf5) downstream of GBF1 are required; for CVB4, no single or paired Arf depletion inhibited replication, suggesting GBF1 supports viral replication through distinct Arf-dependent and Arf-independent mechanisms depending on the virus. |
siRNA and CRISPR-Cas9 Arf depletion (individual and paired), viral replication assays, GBF1 knockdown |
The Journal of general virology |
Medium |
29923822
|
| 2018 |
GBF1 and its substrate Arf1 regulate the spatial organization of mitochondria in a microtubule-dependent manner. GBF1 physically interacts with the mitochondrial membrane protein Miro; GTP-bound Arf1 also interacts with Miro. Inhibition of GBF1 causes collapse of the mitochondrial network toward the centrosome through a two-fold increase in time engaged in retrograde movement, dependent on dynein and Miro. GBF1 inhibition also results in larger mitochondria with more complex morphology. |
Co-immunoprecipitation (GBF1–Miro, Arf1–Miro), GBF1 pharmacological inhibition, immunofluorescence, electron tomography, mitochondrial movement tracking (live imaging), siRNA knockdown of Miro and dynein inhibition |
Scientific reports |
High |
30459446
|
| 2018 |
GBF1 recruitment to cis-Golgi membranes requires its HDS1 and HDS2 C-terminal domains and a heat-labile, protease-sensitive Golgi-localized protein receptor. Arf-GDP localization is critical for GBF1 recruitment, as a TGN-localized Arf-GDP mutant fails to promote GBF1 recruitment. ArfGAP2 and ArfGAP3 do not contribute to GBF1 recruitment. An in vitro GBF1 recruitment assay was established supporting Arf-GDP regulation of GBF1 membrane association. |
In vitro GBF1 recruitment assay (Golgi membranes), domain truncation analysis (in vivo and in vitro), heat/protease treatment of Golgi membranes, Arf-GDP localization mutants, ArfGAP siRNA knockdown |
Journal of cell science |
High |
29507113
|
| 2018 |
Highly conserved residues RDR1168 and LF1266 within α-helices 2 and 6 of the HDS2 domain of GBF1 are critical for GBF1 activity. Alanine substitutions at these positions in BFA-resistant GBF1 compromise Golgi homeostasis, ARF activation, secretion, and cellular viability. These mutations significantly decrease GBF1 Golgi membrane targeting efficiency. |
BFA-resistant GBF1 replacement assay, alanine-scanning mutagenesis, ARF activation assay, secretion assay, Golgi morphology analysis, Golgi targeting quantification |
American journal of physiology. Cell physiology |
Medium |
29443553
|
| 2018 |
GBF1 is phosphorylated on Ser292 and Ser297 by casein kinase-2 in mitosis, allowing recognition and binding by the F-box protein βTrCP, which recruits GBF1 to the SCFβTrCP ubiquitin ligase complex and triggers GBF1 degradation. This phosphorylation-dependent degradation occurs along microtubules at the intercellular bridge of telophase cells and is required for Golgi membrane positioning and postmitotic Golgi reformation. A non-degradable GBF1 mutant inhibits Golgi cluster transport and causes cytokinesis failure. |
Phosphorylation site mapping (Ser292/Ser297), CK2 kinase assay, βTrCP co-immunoprecipitation, SCFβTrCP ubiquitin ligase assay, non-degradable GBF1 mutant expression, immunofluorescence, Golgi inheritance assay, cytokinesis assay |
Cell reports |
High |
29898406
|
| 2019 |
GBF1 modulates ER-Golgi trafficking of von Willebrand factor (VWF) and extracellular matrix proteins in a selective, limiting-factor manner. GBF1 activation by AMPK couples anterograde trafficking to physiological cues (glucose levels); GBF1 modulates both ER exit and TGN exit of VWF, the latter affecting storage organelle size and hemostatic capacity. AMPK activation of GBF1 links cellular energy status to secretory pathway regulation. |
Golgi-associated protein screen, GBF1 level modulation, VWF trafficking assay, secretory granule size quantification, AMPK activation/inhibition experiments, glucose manipulation |
Developmental cell |
Medium |
31056345
|
| 2019 |
C10orf76 is a GBF1 proximal/binding protein identified by BioID proximity biotinylation from enriched Golgi fractions. C10orf76 rapidly cycles on and off GBF1-positive Golgi structures. Its depletion causes Golgi fragmentation, alters GBF1 recruitment to Golgi, and impairs secretion. |
BioID proximity biotinylation + mass spectrometry from Golgi-enriched fractions, co-immunoprecipitation, siRNA knockdown, FRAP, secretion assay |
Molecular & cellular proteomics : MCP |
Medium |
31519766
|
| 2019 |
HCV NS3 (protease domain) physically interacts with the Sec7 domain of GBF1. This interaction was demonstrated by yeast two-hybrid, co-immunoprecipitation, and proximity ligation assays. NS3 overexpression interferes with GBF1 function and alters its intracellular localization. A reverse yeast two-hybrid screen identified an NS3 mutant (N77D/S77D) that neither interacts with GBF1 nor supports viral replication despite conserved protease activity, indicating the NS3-GBF1 interaction is required for HCV replication. |
Yeast two-hybrid (forward and reverse screen), co-immunoprecipitation, proximity ligation assay, NS3 mutagenesis, viral replication assay |
Journal of virology |
High |
30567983
|
| 2019 |
Multiple GBF1 mutants inactive in cellular trafficking (including Sec7 domain mutants) can still support poliovirus RNA replication. The Arf-activating property (but not specific Sec7 primary structure) is indispensable for viral replication. GBF1 is recruited to replication sites redundantly: via direct interaction with viral 3A protein and via determinants in the noncatalytic C-terminal domains of GBF1. |
Systematic GBF1 domain mutagenesis, BFA-resistant GBF1 replacement viral replication assay, 3A binding-deficient GBF1 mutant analysis |
Journal of virology |
Medium |
31375590
|
| 2021 |
Src tyrosine kinase phosphorylates GBF1 on 10 tyrosine residues; phosphorylation of Y876 and Y898 (near the C-terminus of the Sec7 GEF domain) promotes GBF1 binding to Arf1 GTPase. Molecular modeling suggests partial melting of the Sec7 domain and intramolecular rearrangement upon phosphorylation. GBF1 mutants defective for Y876/Y898 phosphorylation prevent Arf1 binding, tubular carrier formation, and GALNTs retrograde relocation; phosphomimetic GBF1 mutants induce retrograde tubules. |
Src kinase assay, phosphopeptide identification by mass spectrometry, co-immunoprecipitation (GBF1-Arf1), phosphomimetic/phosphodeficient GBF1 mutants, live-cell imaging of retrograde tubules, GALNTs localization assay, molecular modeling |
eLife |
High |
34870592
|
| 2021 |
GBF1 activity is required for mouse oocyte meiotic maturation. GBF1 localizes to the spindle periphery during metaphase I. Inhibiting GBF1 activity causes aberrant Golgi accumulation around the spindle (condensation of GM130), disrupts ER distribution, induces ER stress (increased GRP78), alters mitochondrial membrane potential, and impairs polar body formation. GBF1 co-localizes with GM130 at the Golgi in oocytes. |
GBF1 inhibitor treatment (BFA/GCA), immunofluorescence, organelle morphology quantification, mitochondrial membrane potential assay, ER stress marker analysis |
Microscopy and microanalysis |
Low |
33478608
|
| 2022 |
When poliovirus protein 3A engages GBF1, it renders GBF1 a functional hypomorph. Synthetic lethality screening identified ARF1 as the top synthetic lethal partner of GBF1 loss-of-function; disruption of ARF1 selectively killed cells synthesizing 3A alone or in the context of a poliovirus replicon, while leaving uninfected cells viable. |
Synthetic lethality screen, siRNA/genetic ARF1 disruption in 3A-expressing vs. uninfected cells, poliovirus replicon assay |
The Journal of cell biology |
Medium |
36305789
|
| 2023 |
Phosphorylation of specific conserved N-terminal residues of GBF1 (S233, S371, Y377, Y515) differentially regulates its role in cytokinesis versus Golgi homeostasis/secretion. Phosphomimetic GBF1 mutants (and S233A) are fully capable of maintaining Golgi architecture and supporting secretion, but cause multi-nucleation and inhibit progression through cytokinetic bridge resolution, revealing distinct phosphorylation-regulated interaction networks for GBF1 in different cellular processes. |
Phosphomimetic/phosphodeficient site-directed mutagenesis, Golgi homeostasis assay, cargo trafficking assay, cytokinesis assay (multi-nucleation), cell-cycle analysis |
Scientific reports |
Medium |
37604968
|
| 2024 |
AMPK associates with the Golgi and its activation by pharmacological activators leads to Golgi fragmentation via GBF1 phosphorylation at Thr1337. Golgi disassembly upon AMPK activation is blocked in cells expressing a non-phosphorylatable GBF1-T1337A mutant (generated by gene editing). AMPK activation also delays trafficking of a plasma membrane-targeted protein through the Golgi complex. |
AMPK-α subunit gene knockouts, CRISPR gene editing (GBF1-T1337A knock-in), pharmacological AMPK activators, Golgi fragmentation quantification, cargo trafficking assay |
Journal of cell science |
High |
39575556
|
| 2024 |
Enterovirus 3A proteins (from EV-A71, CVB3, poliovirus, EV-D68) interact with GBF1 via N-terminal-conserved 3A residues, sequestering GBF1 and inhibiting ARF1 activation. This induces severe ER stress/UPR and apoptosis via the PERK/CHOP pathway. Pharmaceutical inhibition of PERK suppresses cell death caused by enterovirus infection. ER expansion and accumulation of ER-resident proteins were observed in infected cells. |
3A expression constructs, co-immunoprecipitation, ARF1 activation assay, ER morphology analysis by imaging, UPR/PERK/CHOP pathway markers (Western blot), PERK inhibitor treatment, cell viability assay |
Journal of virology |
Medium |
38904364
|
| 2024 |
GBF1 deficiency in human lens epithelium cells activates XBP1s in the unfolded protein response (UPR) signaling pathway and enhances autophagy in an mTOR-independent manner. A heterozygous GBF1 mutation (T1287I) reduces GBF1 protein levels in human lens epithelium cells. Heterozygous Gbf1 knockout mice display a cataract phenotype. |
Genetic analysis, siRNA/shRNA knockdown in human lens epithelium cell line, Western blot for UPR markers (XBP1s), autophagy assay, Gbf1 heterozygous knockout mouse |
Human genetics |
Medium |
39110251
|
| 2025 |
Substrate stiffness stimulates conventional secretion through a Src-FAK-AMPK-GBF1 signaling axis. Phosphoproteomic analysis identified GBF1 as a mechano-responsive regulator. GBF1 phosphorylation state orchestrates post-Golgi cargo sorting, directing proteins toward secretion versus lysosomal degradation. AMPK acts as a stiffness-dependent upstream regulator of GBF1 phosphorylation. |
Substrate stiffness manipulation, phosphoproteomic analysis, Src/FAK inhibition, AMPK activation/inhibition, secretion assays, lysosomal degradation assays |
bioRxivpreprint |
Low |
|